Company Treace Medical Concepts, Inc.

Equities

TMCI

US89455T1097

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 04:00:00 2024-04-29 pm EDT 5-day change 1st Jan Change
10.65 USD +2.40% Intraday chart for Treace Medical Concepts, Inc. -4.05% -16.47%

Business Summary

Treace Medical Concepts, Inc. is a medical technology company. The Company is focused on advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It also has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of the midfoot as well as its Hammertoe PEEK Fixation System designed to address hammertoe, claw toe and mallet toe deformities. The Lapiplasty, Adductoplasty and Hammertoe PEEK Fixation Systems are comprised of single-use implant kits and reusable instrument trays. The Company sells these products to physicians, surgeons, hospitals and ambulatory surgery centers in the United States.

Number of employees: 516

Sales per Business

USD in Million2022Weight2023Weight Delta
Medical Devices
100.0 %
142 100.0 % 187 100.0 % +31.92%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
100.0 %
142 100.0 % 187 100.0 % +31.92%

Managers

Managers TitleAgeSince
Founder 52 13-12-31
Director of Finance/CFO 54 20-08-31
Compliance Officer 49 22-09-30
Chief Tech/Sci/R&D Officer 42 17-12-31
Chief Operating Officer - -
Chief Tech/Sci/R&D Officer - -
Investor Relations Contact - 23-07-16
Sales & Marketing - 23-08-20
General Counsel - 14-12-31
Sales & Marketing 45 21-07-31

Members of the board

Members of the board TitleAgeSince
Director/Board Member 66 20-11-19
Director/Board Member 65 15-02-28
Chairman 77 14-06-30
Director/Board Member 62 20-11-19
Director/Board Member 51 22-09-30
Director/Board Member 63 22-08-31
Founder 52 13-12-31
Director/Board Member 59 21-09-30
Director/Board Member 56 21-09-30

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 61,937,218 44,640,038 ( 72.07 %) 1,218 ( 0.001967 %) 72.07 %

Shareholders

NameEquities%Valuation
10,958,135 17.74 % 143 M $
Vanguard Fiduciary Trust Co.
6.953 %
4,293,789 6.953 % 56 M $
BlackRock Advisors LLC
5.617 %
3,468,721 5.617 % 45 M $
Morgan Stanley Investment Management, Inc.
5.049 %
3,117,734 5.049 % 41 M $
William Blair Investment Management LLC
4.644 %
2,868,034 4.644 % 37 M $
Armistice Capital LLC
4.625 %
2,856,000 4.625 % 37 M $
2,385,033 3.862 % 31 M $
Divisadero Street Capital Management LP
2.834 %
1,750,000 2.834 % 23 M $
TimesSquare Capital Management LLC
2.832 %
1,749,120 2.832 % 23 M $
CIBC Private Wealth Group LLC
2.364 %
1,460,081 2.364 % 19 M $

Company contact information

Treace Medical Concepts, Inc.

100 Palmetto Park Place

32081, Ponte Vedra Beach

+

http://www.treace.com
address Treace Medical Concepts, Inc.(TMCI)
  1. Stock Market
  2. Equities
  3. TMCI Stock
  4. Company Treace Medical Concepts, Inc.